Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Metallophosphoesterase 1 (MPPE1) is an enzyme essential for the transport and maturation of glycosylphosphatidylinositol (GPI)-anchored proteins. It catalyzes the removal of a side-chain ethanolamine-phosphate (EtNP) from the second mannose of the GPI-anchor protein intermediate, a necessary lipid remodeling step for GPI-anchor maturation. This process is crucial for efficient transport of GPI-anchor proteins from the endoplasmic reticulum to the Golgi apparatus. MPPE1 is primarily localized to the Golgi apparatus and nucleoplasm. While MPPE1 has been associated in genetic contexts with diseases such as Bejel and Yaws, no direct links to cancer, inflammatory, or neurodegenerative diseases are known as of now, nor are any targeting drugs or safety concerns described in current literature[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Metallophosphoesterase 1 (MPPE1).